V

Vicore Pharma Holding AB
D

VCRE

11.410
USD
-0.57
(-4.76%)
مغلق
حجم التداول
373
الربح لكل سهم
0
العائد الربحي
-
P/E
-6
حجم السوق
321,220,698
المقالات
المزيد

العنوان: Vicore Pharma Holding AB

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.